Ponad 7000 publikacji medycznych!
Statystyki za 2021 rok:
odsłony: 8 805 378
Artykuły w Czytelni Medycznej o SARS-CoV-2/Covid-19

Poniżej zamieściliśmy fragment artykułu. Informacja nt. dostępu do pełnej treści artykułu
© Borgis - Nowa Medycyna 2/2021, s. 41-58 | DOI: 10.25121/NM.2021.28.2.41
*Radosław Cylke1, Magdalena Kwapisz1, Agata Ostaszewska1, Małgorzata Kołodziejczak1, 2
Diagnosis and treatment of faecal incontinence – the current state of knowledge, literature review
Diagnostyka i leczenie nietrzymania stolca – aktualny stan wiedzy, przegląd piśmiennictwa
1Department of General Surgery and Transplantology, University Clinical Center, Medical University of Warsaw, Infant Jesus Clinical Hospital, Warsaw
2Warsaw Proctology Center, St. Elisabeth Hospital, Mokotów Medical Center, Warsaw
Streszczenie
Inkontynencja istotnie wpływa na codzienne funkcjonowanie pacjentów i potrafi znacząco pogorszyć jakość ich życia, prowadząc do społecznego inwalidztwa. Do najczęstszych przyczyn nietrzymania gazów i stolca należą uszkodzenia okołoporodowe (mechaniczny uraz mięśni zwieraczy lub rozciągnięcie nerwu sromowego w trakcie porodu siłami natury) i powikłania po zabiegach proktologicznych. Częstość występowania nietrzymania stolca jest szacowana przez różnych autorów między 2,2 a 25%. Problem ten dotyka ludzi we wszystkich grupach wiekowych, głównie jednak osoby starsze, częściej kobiety niż mężczyzn.
W artykule dokonano przeglądu metod diagnostycznych inkontynencji oraz sposobów terapii w oparciu o najnowsze doniesienia na ten temat. Większość badaczy jest zgodna, że, z wyjątkiem rozległych urazów zwieraczy, podstawą leczenia nietrzymania stolca są metody zachowawcze, a w przypadku ich nieskuteczności – zabiegi instrumentalne lub operacyjne. Pomimo mnogości metod leczenia tej trudnej choroby, nie ma idealnego postępowania terapeutycznego, gdyż najczęściej etiologia inkontynencji jest wieloczynnikowa, stąd i działanie terapeutyczne powinno się odbywać na kilku płaszczyznach. Leczenie należy prowadzić w ośrodku dedykowanym pacjentom proktologicznym, wyposażonym w odpowiednie narzędzia diagnostyczne i kadrę specjalistów.
Summary
Incontinence significantly affects the daily functioning of patients and can severely deteriorate their quality of life, leading to social disability. The most common causes of gas and faecal incontinence include obstetric injuries (mechanical trauma to the sphincter muscles or stretching of the pudendal nerve during vaginal delivery) and complications after anorectal procedures. The incidence of faecal incontinence is estimated by various authors between 2.2 and 25%. The problem affects all age groups, but mainly the elderly, with higher rates among women than men.
The paper presents a review of diagnostic and therapeutic methods for incontinence based on the latest reports. Most researchers agree that, except for extensive sphincter injuries, conservative methods are the mainstay treatment for faecal incontinence, while instrumental or surgical procedures are used in the event of their failure. Despite the multitude of therapeutic methods for this difficult disease, there is no ideal procedure as the aetiology of incontinence is usually multifactorial, hence the therapeutic management should be incorporated on several levels. Treatment should be performed in a centre dedicated to proctological patients, equipped with appropriate diagnostic tools and specialist personnel.



Introduction
Faecal incontinence (FI) is a disease characterised by the lack of control over solid or liquid bowel contents. There is also a concept of anal incontinence, when there is additional loss of control over gases (1, 2). The incidence of faecal incontinence is estimated by various authors between 2.2 and 25% (2-4). The problem affects all age groups, but mainly the elderly, with higher prevalence among women (5). Incontinence significantly affects the daily functioning of patients and can severely deteriorate their quality of life, leading to social disability. Despite such significant consequences, patients are often too embarrassed to report continence problems to their GPs. Therefore, clinicians should take the initiative and ask direct questions about incontinence in the case of patients with risk factors for faecal incontinence (1).
Mechanisms underlying faecal continence
The mechanism for efficient faecal continence depends on different factors, including anatomical factors (e.g. the presence of venous plexuses, the integrity of the anal sphincters and the puborectalis muscle, the anorectal angle, transverse rectal folds), as well as adequate anorectal sensation, and correct rectal compliance (6). The movement of faecal masses is conditioned by high-amplitude peristaltic contractions, most often occurring after waking up or a meal. The basic mechanism underlying bowel movement was first described already in 1935 by Denny-Brown and Robertson (7). Stretching of the rectum induces a reaction in the form of its subsequent contraction, combined with the relaxation of the anal sphincters. During this time, other pelvic floor muscles, the puborectalis muscle in particular, also relax. The increase in intra-abdominal pressure caused by squeezing plays a certain role in the defecation process. Normally, if the time for a bowel movement seems inappropriate, it can be postponed due to voluntary contractions of the external anal sphincter (EAS) and the puborectalis muscle (6). The ability to assess the nature of the contents accumulating in the rectum (solid/loose stool, gas) is also necessary for the proper functioning of this mechanism. Faecal continence and bowel movement are therefore complicated mechanisms that depend not only on the proper functioning of the anal sphincter and the pelvic floor, but also on the correct somatovisceral reflexes, largely dependent on the efficiency of the sensory receptors located in the rectal ampulla.
Aetiology
Proper diagnosis of the source of the problem is extremely important for the implementation of appropriate treatment. In terms of the aetiology of faecal incontinence, the clearest classification system is presented in the “Rome IV Guidelines” (tab. 1) (8).
Tab. 1. Aetiology of faecal incontinence
1. Weakening of the anal sphincters:
• traumatic:
  – obstetric
  – surgical (e.g. haemorrhoidectomy, sphincterotomy, anal fistula surgeries)
• non-traumatic:
  – systemic scleroderma
  – idiopathic degeneration of the internal anal sphincter
• neuropathy:
  – peripheral (e.g. pudendal nerve)
  – generalised (e.g. diabetic)
2. Diseases of the pelvic floor:
• rectal prolapse
• descending perineum syndrome
3. Diseases affecting rectal volume/sensation:
• inflammatory:
  – radiation proctitis
  – Crohn’s disease
  – ulcerative colitis
• anal and rectal surgeries:
  – bowel containers
  – anterior rectal resection
• poor reception of rectal sensory stimuli
• rectal hypersensitivity
4. CNS diseases:
• dementia
• stroke
• brain tumours
• multiple sclerosis
• spinal cord injury
5. Mental disorders
6. Intestinal disorders:
• irritable bowel syndrome
• diarrhoea after gallbladder surgery
• constipation
• faecal retention with uncontrolled leakage of liquid content
The most common causes of faecal incontinence include obstetric injuries (mechanical trauma to the sphincter muscles or stretching of the pudendal nerve during vaginal delivery) and complications after anorectal procedures.
Factors increasing the risk of faecal incontinence symptoms include chronic diarrhoea, previous cholecystectomy, smoking, rectocele, sudden urges to pass a stool, high BMI, advanced age, comorbidities, sphincter muscle injury (e.g. obstetric trauma, surgery) and poor physical activity (2, 8). Chronic diseases particularly associated with an increased risk of faecal incontinence include diabetes mellitus, stroke, multiple sclerosis, Parkinson’s disease, systemic scleroderma, myotonic dystrophy, spinal cord injuries, faecal impaction, pelvic organ prolapse, diarrhoeas, inflammation of the colon and rectum, and radiation proctitis (9).
Faecal incontinence grading system
There is no uniform approach to the classification of faecal incontinence, therefore the aetiology of the disease, pathophysiology, type of incontinence and its intensity (severity of symptoms) should be assessed individually in each case (2).
The type of stool incontinence can be assessed with a 3-grade scale: grade I - leakage and difficulty controlling gas and liquid faeces, grade II - inability to control gas and liquid faeces, and limited or lost control over loose stool, grade III - inability to control a properly formed stool (10). We can also distinguish urge, passive, and mixed incontinence (1, 2). In the first case, the patient experiences a pressing urge that cannot be postponed, and is most often associated with weakened anal sphincter muscles. The second type involves involuntary stool loss (without urge), usually caused by nerve damage. Anorectal manometry is an excellent tool to help distinguish between the two types of faecal incontinence.
The severity of faecal incontinence can also be determined by considering the subjective symptoms of patients. The currently used scales include the Fecal Incontinence Severity Index (FISI) by Rockwood, Jorge-Wexner score, Vaizey score, Pescatori score, American Medical Systems Scale – Fecal Incontinence Scoring System or Holschneider score (which also takes into account manometric results) (5). In our centre, we use the Jorge-Wexner score (also known as the Cleveland score) (tab. 2) (11).
Tab. 2. The Jorge-Wexner incontinence score
Type of incontinenceFrequency
NeverRarelySometimesOftenAlways
Solid01234
Liquid01234
Gas01234
Pads01234
Lifestyle modification01234
never – 0; rarely – < 1 x week; sometimes– ≤ 1 x week; often – < 1 x day; always – ≥ 1 day
Result: 0 – excellent control; 20 – total incontinence
Diagnosis
Due to the complex aetiology of the problem, all patients with faecal incontinence should undergo full, thorough diagnosis based on medical history and physical (proctological) examination. The perianal area should be inspected for scars, skin lesions/maceration, leakage of contents from the anus, perianal fistulas, enlarged haemorrhoidal plexuses, prolapsed anal mucosa, and thinning of the rectovaginal septum (which may indicate the presence of rectocele). The Valsalva maneuver may reveal rectal/uterine prolapse, or pelvic floor depression. Rectal examination allows for the preliminary exclusion of pathological resistance in the rectum and provides information on the length of the anal canal, the tension of the sphincter at rest and at squeezing, as well as an assessment of the thickness of the anal sphincter. Sensory disturbances may indicate neurological aetiology of impaired bowel movements (12). When planning treatment strategy, it is essential to verify whether fecal incontinence is caused by morphological damage to the sphincter muscles or a neurogenic disorder.
According to the 2014 ACG (American College of Gastroenterology) guidelines, anorectal manometry, and balloon expulsion test (BET) should be performed first in patients in whom conservative treatment has failed. If sphincter complex dysfunction is found, the diagnosis should be extended to include imaging techniques (endoanal ultrasound [EAUS] or magnetic resonance imaging [MRI]) and electromyography (EMG) (1). These guidelines are in line with the recommendations of another American organisation, i.e. the American Society of Colon and Rectal Surgeons (13). These tests are necessary to plan a potential repair.
Many imaging and functional tests can be used in the diagnosis of faecal incontinence, such as: endoscopy of the lower GI tract, endosonography, MRI, defecography, manometry, electrography with the assessment of the asymmetry of sphincter innervation, barostat measurement, central and peripheral magnetic stimulation, evaluation of anorectal temperature sensation and electrical stimulation, as well as the assessment of functional morphology and the cells of Cajal. In this paper, we will focus on selected diagnostic methods that are most often used in everyday practice.
Endoscopy of the lower gastrointestinal tract
It is necessary to perform an endoscopic examination of the lower gastrointestinal tract (colonoscopy or sigmoidoscopy) before initiating the treatment of faecal incontinence to exclude potential organic aetiology (cancer, adenoma, inflammatory bowel diseases). It also allows for collecting mucosal biopsy to diagnose the cause of disturbed bowel movement rhythm (8).
Endosonography
Endosonography (transrectal ultrasound) is an essential diagnostic test for any symptoms of faecal incontinence. It enables an accurate assessment of the integrity of the sphincter muscles and visualisation of morphological changes ranging from minor atrophy to complete disruption of their continuity. It also allows for visualising the layered structure of the anal canal, as well as both anal sphincters and the puborectalis muscle. Its relatively low cost, short performance time and simplicity are undoubted advantages of the method. Subjectivity and low measurement repeatability, which is an important diagnostic element in patients with incontinence, especially when assessing the thickness of the sphincter muscle, are disadvantages of this technique (14). EAUS is the leading imaging method for the internal anal sphincter (IAS). However, it shows lower accuracy in assessing EAS damage than, for example, MRI, due to its poorer ability to visualise the muscle outlines against the background of the ischioanal fat tissue (the MRI signal from the striated muscles significantly differs from the one in fat tissue) (15). However, comparative studies of MRI and three-dimensional endosonography have shown high consistency of measurements in both methods despite the tendency of ultrasonography to overestimate EAS thickness and underestimate IAS thickness (16). The primary goal of the investigation is to determine whether the reported symptoms of incontinence are caused by morphological damage to the sphincters. The extent of the damage is measured by showing which of the muscles has been damaged, at what level and in which part of the circumference, what is the size of the defect (> or < 50% of the circumference), and what is the condition of the remaining sphincter mass. Exclusion of morphological abnormalities and a correct image of the sphincter muscles raise the suspicion of a neurogenic aetiology.
Sector, sector/linear and mechanical (rotating) transducers with high frequencies (7.0-16 MHz) are used for the imaging of the anal canal. No preparation is needed. Inserting the transducer several centimeters deep into the anal canal allows for the assessment of the anal canal on three levels: the upper (the loop of the puborectalis muscle, the upper part of the external sphincter), the middle (external and internal sphincter) and the lower level (distal part of the external anal sphincter). Additionally, the method allows for cross-sectional imaging of the layered structure of the anal canal wall (inner subepithelial layer, internal sphincter, intersphincteric zone, external anal sphincter along with the puborectalis muscle) (17). As the possibility of obtaining a three-dimensional image significantly improves endosonographic accuracy of the examination, the advantage of MRI becomes less important.
MRI
Magnetic resonance imaging plays an important role in the diagnosis of patients with suspected congenital anatomical malformations. It is also useful in cases of complex anal fistulas, which, as a focus of continuous infection, may cause persistent symptoms described as incontinence. It allows the visualisation of the anatomy of the sphincters and all pelvic floor structures without patient exposure to harmful radiation (18). MRI with torso pelvic or endorectal coil is considered the method of choice in the diagnosis of inflammatory diseases. The advantages of MRI include multidimensionality, tissue specificity and measurement repeatability (16). Good quality image of the anal sphincters is obtained both in MRI and endosonography, therefore the choice of the method depends largely on its availability and the experience in a given centre.
Defecography
A test using X-rays to assess the behaviour of the anus and rectum at various stages of bowel movement is one of the basic diagnostic methods allowing for the assessment of bowel movement disorders. Approximately 300 mL of thick barium paste for rectal administration is used as a contrast agent. Defecography allows for the assessment of the length of the anal canal and the anorectal angle, pelvic floor mobility and the time of barium paste expulsion in real time (19). The method can be used to diagnose, among other things, anatomical and functional features that impair defecation, including rectocele, intussusception or rectal prolapse. MR defecography is a type of X-ray defecography (20).
Manometry

Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Mam kod dostępu
  • Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu albo wszystkich artykułów (w zależności od wybranej opcji), należy wprowadzić kod.
  • Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.
  • Aby kupić kod proszę skorzystać z jednej z poniższych opcji.

Opcja #1

24

Wybieram
  • dostęp do tego artykułu
  • dostęp na 7 dni

uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony

Opcja #2

59

Wybieram
  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 30 dni
  • najpopularniejsza opcja

Opcja #3

119

Wybieram
  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 90 dni
  • oszczędzasz 28 zł
Piśmiennictwo
1. Wald A, Bharucha AE, Cosman BC et al.: ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol 2014; 109(8): 1141-1157; (Quiz) 058.
2. Bharucha AE, Dunivan G, Goode PS et al.: Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop. Am J Gastroenterol 2015; 110(1): 127-136.
3. Norton C, Whitehead WE, Bliss DZ et al.: Management of fecal incontinence in adults. Neurourol Urodyn 2010; 29(1): 199-206.
4. Duelund-Jakobsen J, Worsoe J, Lundby L et al.: Management of patients with faecal incontinence. Therap Adv Gastroenterol 2016; 9(1): 86-97.
5. Herman RM, Wałęga P, Sobocki J et al.: Nowoczesna diagnostyka i możliwości leczenia nietrzymania stolca. Postępy Nauk Medycznych 2006; 5: 216-234.
6. Bharucha AE: Pelvic floor: anatomy and function. Neurogastroenterol Motil 2006; 18(7): 507-519.
7. Denny-Brown D, Robertson E: An investigation of the nervous control of defaecation. Brain 1935; 58: 256-310.
8. Szczepanek M, Goncerz G: Choroby czynnościowe układu pokarmowego – wytyczne rzymskie IV (2016). Część IV: Choroby czynnościowe odbytnicy i odbytu. Med Prakt 2018; 10: 59-68.
9. Wald A: Update on the Management of Fecal Incontinence for the Gastroenterologist. Gastroenterol Hepatol (N Y) 2016; 12(3): 155-164.
10. Winkler R, Otto P, Schiedeck T (tłum. Dziki A.): Proktologia praktyczna. Urban & Partner, Wrocław 2011.
11. Jorge JM, Wexner SD: Etiology and management of fecal incontinence. Dis Colon Rectum 1993; 36(1): 77-97.
12. Alavi K, Chan S, Wise P et al.: Fecal Incontinence: Etiology, Diagnosis, and Management. J Gastrointest Surg 2015; 19(10): 1910-1921.
13. Paquette IM, Varma MG, Kaiser AM et al.: The American Society of Colon and Rectal Surgeons’ Clinical Practice Guideline for the Treatment of Fecal Incontinence. Dis Colon Rectum 2015; 58(7): 623-636.
14. Beets-Tan R, Morren G, Beets G et al.: Measurement of anal sphincter muscles: endoanal US, andoanal MR imaging, or phassed-array MR imaging? A study with healthy volunteers. Radiology 2021; 220: 81-89.
15. Malouf AJ, Williams AB, Halligan S et al.: Prospective assessment of accuracy of endoanal MR imaging and endosonography in patients with fecal incontinence. AJR Am J Roentgenol 2000; 175(3): 741-745.
16. Williams AB, Bartram CI, Halligan S et al.: Endosonographic anatomy of the normal anal canal compared with endocoil magnetic resonance imaging. Dis Colon Rectum 2002; 45(2): 176-183.
17. Radkiewicz J, Sudoł-Szopińska I, Wójtowicz M et al.: Anatomia prawidłowa i ultrasonograficzna struktur dna miednicy. Gin Prakt 2006; 4: 26-30.
18. Andrews CN, Bharucha AE: The etiology, assessment, and treatment of fecal incontinence. Nat Clin Pract Gastroenterol Hepatol 2005; 2(11): 516-525.
19. Carrington EV, Scott SM, Bharucha A et al.: Expert consensus document: Advances in the evaluation of anorectal function. Nat Rev Gastroenterol Hepatol 2018; 15(5): 309-323.
20. Bertschinger KM, Hetzer FH, Roos JE et al.: Dynamic MR imaging of the pelvic floor performed with patient sitting in an open-magnet unit versus with patient supine in a closed-magnet unit. Radiology 2002; 223(2): 501-508.
21. Herman R, Wałęga P: Badania czynnościowe dolnego odcinka przewodu pokarmowego. [W:] Bielecki K, Dziki A (red.): Proktologia. PZWL, Warszawa 2000: 58-75.
22. Rasmussen OO: Anorectal function. Dis Colon Rectum 1994; 37(4): 386-403.
23. Snooks SJ, Swash M, Mathers SE et al.: Effect of vaginal delivery on the pelvic floor: a 5-year follow-up. Br J Surg 1990; 77(12): 1358-1360.
24. Lefaucheur JP: Neurophysiological testing in anorectal disorders. Muscle Nerve 2006; 33(3): 324-333.
25. Fejka MD 3rd: Fecal incontinence: A review of current treatment options. JAAPA 2016; 29(9): 27-30.
26. Minguez M, Herreros B, Sanchiz V et al.: Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology 2004; 126(1): 57-62.
27. Chiarioni G, Kim SM, Vantini I et al.: Validation of the balloon evacuation test: reproducibility and agreement with findings from anorectal manometry and electromyography. Clin Gastroenterol Hepatol 2014; 12(12): 2049-2054.
28. Fragkos KC, Zarate-Lopez N, Frangos CC: What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans. Therap Adv Gastroenterol 2016; 9(3): 282-301.
29. Garsed K, Chernova J, Hastings M et al.: A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut 2014; 63(10): 1617-1625.
30. Deutekom M, Dobben AC: Plugs for containing faecal incontinence. Cochrane Database Syst Rev 2015; (7): CD005086.
31. Takahashi-Monroy T, Morales M, Garcia-Osogobio S et al.: SECCA procedure for the treatment of fecal incontinence: results of five-year follow-up. Dis Colon Rectum 2008; 51(3): 355-359.
32. Efron JE, Corman ML, Fleshman J et al.: Safety and effectiveness of temperature-controlled radio-frequency energy delivery to the anal canal (Secca procedure) for the treatment of fecal incontinence. Dis Colon Rectum 2003; 46(12): 1606-1616; discussion 16-18.
33. Wexner SD, Coller JA, Devroede G et al.: Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg 2010; 251(3): 441-449.
34. Mellgren A, Wexner SD, Coller JA et al.: Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum 2011; 54(9): 1065-1075.
35. Patton V, Wiklendt L, Arkwright JW et al.: The effect of sacral nerve stimulation on distal colonic motility in patients with faecal incontinence. Br J Surg 2013; 100(7): 959-968.
36. Chapple CR, Haab F, Cervigni M et al.: An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Eur Urol 2005; 48(3): 488-494.
37. Graf W, Mellgren A, Matzel KE et al.: Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet 2011; 377(9770): 997-1003.
38. La Torre F, de la Portilla F: Long-term efficacy of dextranomer in stabilized hyaluronic acid (NASHA/Dx) for treatment of faecal incontinence. Colorectal Dis 2013; 15(5): 569-574.
39. Mongardini M, Giofre M: Management of Fecal Incontinence: Current Treatment Approaches and Future Perspectives. Springer 2016.
40. Kołodziejczak M, Ciesielski P: Atlas technik operacyjnych w proktologii. Borgis, Warszawa 2019.
41. Pickrell KL, Broadbent TR, Masters FW et al.: Construction of a rectal sphincter and restoration of anal continence by transplanting the gracilis muscle; a report of four cases in children. Ann Surg 1952; 135(6): 853-862.
42. Mundy L, Merlin TL, Maddern GJ et al.: Systematic review of safety and effectiveness of an artificial bowel sphincter for faecal incontinence. Br J Surg 2004; 91(6): 665-672.
43. Norton C, Burch J, Kamm MA: Patients’ views of a colostomy for fecal incontinence. Dis Colon Rectum 2005; 48(5): 1062-1069.
44. Chermansky CJ, Tarin T, Kwon DD et al.: Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology 2004; 63(4): 780-785.
45. Carr LK, Steele D, Steele S et al.: 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19(6): 881-883.
46. Imamura T, Ishizuka O, Kinebuchi Y et al.: Implantation of autologous bone-marrow-derived cells reconstructs functional urethral sphincters in rabbits. Tissue Eng Part A 2011; 17(7-8): 1069-1081.
47. Stangel-Wojcikiewicz K, Jarocha D, Piwowar M et al.: Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation. Neurourol Urodyn 2014; 33(3): 324-330.
48. Lorenzi B, Pessina F, Lorenzoni P et al.: Treatment of experimental injury of anal sphincters with primary surgical repair and injection of bone marrow-derived mesenchymal stem cells. Dis Colon Rectum 2008; 51(4): 411-420.
49. White AB, Keller PW, Acevedo JF et al.: Effect of myogenic stem cells on contractile properties of the repaired and unrepaired transected external anal sphincter in an animal model. Obstet Gynecol 2010; 115(4): 815-823.
50. Salcedo L, Penn M, Damaser M et al.: Functional outcome after anal sphincter injury and treatment with mesenchymal stem cells. Stem Cells Transl Med 2014; 3(6): 760-767.
51. Frudinger A, Kolle D, Schwaiger W et al.: Muscle-derived cell injection to treat anal incontinence due to obstetric trauma: pilot study with 1 year follow-up. Gut 2010; 59(1): 55-61.
52. Frudinger A, Pfeifer J, Paede J et al.: Autologous skeletal-muscle-derived cell injection for anal incontinence due to obstetric trauma: a 5-year follow-up of an initial study of 10 patients. Colorectal Dis 2015; 17(9): 794-801.
53. Giori A, Tremolada C, Vailiti R et al.: Recovery of Function in Anal Incontinence after Micro-Fragmented Fat Graft (Lipogems®) Injection: Two Years Follow Up of the First 5 Cases. CellR4 2016; 3(2): e1544.
54. Bhide AA, Tailor V, Fernando R et al.: Posterior tibial nerve stimulation for overactive bladder-techniques and efficacy. Int Urogynecol J 2020; 31(5): 865-870.
55. Leroi AM, Siproudhis L, Etienney I et al.: Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (CONSORT 1a). Am J Gastroenterol 2012; 107(12): 1888-1896.
56. Knowles CH, Horrocks EJ, Bremner SA et al.: Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial. Lancet 2015; 386(10004): 1640-1648.
57. Richter HE, Matthews CA, Muir T et al.: A vaginal bowel-control system for the treatment of fecal incontinence. Obstet Gynecol 2015; 125(3): 540-547.
58. Sokol ER: Management of fecal incontinence – focus on a vaginal insert for bowel control. Med Devices (Auckl) 2016; 9: 85-91.
59. Lehur PA, McNevin S, Buntzen S et al.: Magnetic anal sphincter augmentation for the treatment of fecal incontinence: a preliminary report from a feasibility study. Dis Colon Rectum 2010; 53(12): 1604-1610.
60. Pakravan F, Helmes C: Magnetic anal sphincter augmentation in patients with severe fecal incontinence. Dis Colon Rectum 2015; 58(1): 109-114.
61. Sugrue J, Lehur PA, Madoff RD et al.: Long-term Experience of Magnetic Anal Sphincter Augmentation in Patients With Fecal Incontinence. Dis Colon Rectum 2017; 60(1): 87-95.
otrzymano: 2021-04-05
zaakceptowano do druku: 2021-04-26

Adres do korespondencji:
*Radosław Cylke
Katedra i Klinika Chirurgii Ogólnej i Transplantacyjnej Warszawski Uniwersytet Medyczny
ul. Nowogrodzka 59, 02-006 Warszawa
radek.cylke@gmail.com

Nowa Medycyna 2/2021
Strona internetowa czasopisma Nowa Medycyna